|
Home
CME Live Seminars
About the Program
Quick Order
Hotel Registration
Auto Rental
Accreditation
Cancellation Policy
Testimonials
CME Video DVD
CME Audio CD/MP3
Subscribe
Request Brochure
Hold Seat
Testing Online
Faculty
Resources
Contact Us
|
|
|
|
Live CME Seminars
Primary Care CME - Women's Health CME |
|
|
by Herbert L. Muncie, Jr., M.D. - Louisiana State University Health Sciences Center School of Medicine; Professor of Family Medicine and Director, Medical Student
Education, Department of Family Medicine; New Orleans, LA and Albert J. Peters, D.O., F.A.C.O.G. - Sher Institute for Reproductive Medicine (SIRM); Medical Director; New Jersey.
Learning Objectives
What do our past participants have to say?
Refer a Colleague to Our Website
|
|
NARRATIVE DESCRIPTION: Following this course, the participant should be able to appraise the typical etiology of the Gynecologic disorders presented; apply improved diagnostic methods and ordering of tests in the Primary Care office and Emergency Medicine setting; choose the appropriate treatment and drugs for commonly seen GYN disorders as well as identify treatment failures vs. recurrence. This activity is expected to result in improved competence when making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.
The emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives, with a focus on diagnosis, treatment and when to refer. Since Women’s Health and Gynecology is a field of medicine that covers various aspects of different specialties and is highly requested, this course was designed to cover a wide range of topics essential to all practitioners at the level of a practicing physician.
| | Day 1 |
Amenorrhea. Anemia – A Finding, Not Yet a Diagnosis. Abnormal Uterine Bleeding. Hormonal Contraceptives: Good, Bad and Controversial. |
| Day 2 |
Chronic Anovulation. Osteoporosis: Diagnosis and Treatment. Menopause: Myths and Realities. Migraine Headaches – Update on Diagnosis and Treatment. |
| Day 3 |
Hirsutism. Evaluation and Initial Management: Benign Breast Disease. Gynecologic Complementary Therapy. Coronary Artery Disease in Women. |
| Day 4 |
Treatment of Sexually Transmitted Infections. Premenstrual Syndrome. Venous Thromboembolism (VTE): Diagnosis and Treatment. Pelvic Pain. |
| Day 5 |
Adult Health Screening and Immunizations – Evidence-Based Approach. Gynecologic Emergencies. Use and Interpretation of Thyroid Tests. Endometriosis. |
|
|
Primary Care and Women’s Health: An Update and Review
November 8-12, 2010
Location: Hyatt Regency Sarasota, Florida
| SPECIFIC OBJECTIVES
| | Day 1 | Amenorrhea - Upon completion of this session, the participant should be able to:
| 1. | Assess the various causes of primary and secondary amenorrhea and their associated health risks, as well as apply the appropriate evaluation for both.
| | 2. | Provide therapy to the patient with regard to hormone replacement therapy or infertility.
| | 3. | Categorize the various anatomic and functional levels of distinction with respect to amenorrhea.
| | Anemia – A Finding, Not Yet a Diagnosis - Upon completion of this session, using the Cochrane Abstract Database and AAFP Guidelines, the participant should be able to:
| | 1. | Determine the etiologies for common anemia.
| | 2. | Construct the diagnostic evaluation needed to determine the etiology of anemia.
| | 3. | Recommend the evidence-based therapeutic options for each identified anemia.
| | 4. | Formulate the appropriate follow-up evaluations for assessing the treatment efficacy for each anemia.
| | Abnormal Uterine Bleeding - Upon completion of this session, the participant should be able to:
| | 1. | Define abnormal uterine bleeding.
| | 2. | Differentiate between functional and organic causes.
| | 3. | Manage most non-surgical etiologies of this problem.
| | Hormonal Contraceptives: Good, Bad and Controversial - Upon completion of this session, using the ACOG Practice Guidelines and the Cochrane Abstract Database, the participant should be able to:
| | 1. | Appraise the pharmacologic differences in oral contraceptives and their role in contraceptive efficacy.
| | 2. | Differentiate the relative and absolute contraindications to oral contraceptives.
| | 3. | Determine the circumstances that would be eligible for emergency contraception and the most appropriate method of emergency contraception for each situation.
|
| | Day 2 | Chronic Anovulation - Upon completion of this session, the participant should be able to:
| 1. | Discriminate between the hypothalamic, pituitary and ovarian causes of anovulation.
| | 2. | Investigate associated health risks.
| | 3. | Formulate an appropriate treatment regimen.
| | Osteoporosis: Diagnosis and Treatment - Upon completion of this session, using the USPSTF, NOF Guidelines and the Cochrane Abstract Database, the participant should be able to:
| | 1. | Interpret the risk factors that increase a patient’s risk of an osteoporosis fracture.
| | 2. | Recommend the diagnostic testing for patients at risk for osteoporosis.
| | 3. | Select the therapeutic class of medication to treat osteoporosis based upon their indications and side effects.
| | 4. | Discuss the therapeutic role of repeating the DXAS scan in patient treated for osteoporosis.
| | Menopause: Myths and Realities - Upon completion of this session, the participant should be able to:
| | 1. | Classify the various issues that face the menopausal woman.
| | 2. | Differentiate between true concerns and current anecdotal myths.
| | 3. | Discuss topics such as: osteoporosis, cardiovascular disease, breast cancer and endometrial cancer as well as their current therapies.
| | 4. | Critically evaluate evidence-based menopause literature.
| | Migraine Headaches – Update on Diagnosis and Treatment - Upon completion of this session, using the International Headache Society and U.S. Headache Consortium Guidelines and the National Guideline Clearinghouse and the evidence-based reports from Clinical Evidence, the participant should be able to:
| | 1. | Develop the approach for evaluating a patient with possible migraine headaches based upon evidence-based guidelines.
| | 2. | Relate the advantages of supportive therapy and lifestyle changes in treating migraine headaches compared to pharmacologic therapy.
| | 3. | Recommend the pharmacologic options for treating the acute pain of a migraine headache based upon evidence-based guidelines.
| | 4. | Design a prophylactic therapy regimen for patients with recurrent migraine headaches.
|
| | Day 3 | Hirsutism - Upon completion of this session, the participant should be able to:
| 1. | Understand the pathophysiology of abnormal body hair growth in women.
| | 2. | Differentiate the source of androgen excess.
| | 3. | Employ current treatment options.
| | Evaluation and Initial Management: Benign Breast Disease - Upon completion of this session, using the American Cancer Society Guidelines and the Cochrane Abstract Database, the participant should be able to:
| | 1. | Differentiate the sign and symptoms associated with benign breast disease from breast cancer.
| | 2. | Formulate an evidence-based evaluation for breast pain, breast lumps, and nipple discharge.
| | 3. | Recommend the evidence-based treatment options for breast pain, nipple discharge and breast infections.
| | Gynecologic Complementary Therapy - Upon completion of this session, the participant should be able to:
| | 1. | Define various forms of complementary medicine such as acupressure, acupuncture, herbal therapy, massage therapy, etc.
| | 2. | Answer general questions from patients regarding various complementary therapies.
| | 3. | Describe the basic mechanism of action with various complementary therapies.
| | 4. | Apply complementary therapies to various gynecologic problems such as PMS, infertility and ovulatory disorders using evidence-based literature.
| | Coronary Artery Heart Disease in Women - Upon completion of this session, using the ACC and USPSTF Guidelines and the Cochrane Abstract Database, the participant should be able to:
| | 1. | Differentiate the symptoms that women with CAD exhibit in contrast to those experienced by men.
| | 2. | Recommend the evidence-based interventions to prevent CAD in women.
| | 3. | Formulate the EBM recommendations that will best treat the risk factors for CAD in women.
|
| | Day 4 | Treatment of Sexually Transmitted Infections - Upon completion of this session, using the CDC Guidelines and the Cochrane Abstract Database, the participant should be able to:
| 1. | Determine the appropriate diagnostic testing for each presenting complaint that is suggestive of a sexually transmitted infection.
| | 2. | Recommend the evidence-based therapy for the commonly encountered sexually transmitted infections.
| | 3. | Determine the appropriate follow-up testing and evaluations for each sexually transmitted infection.
| | Premenstrual Syndrome - Upon completion of this session, the participant should be able to:
| | 1. | Identify patients with this disorder.
| | 2. | Provide education for the patient as to the myths and realities of the premenstrual syndrome.
| | 3. | Utilize current effective therapies.
| | 4. | Formulate on appropriate differential diagnosis for PMS.
| | Venous Thromboembolism (VTE): Diagnosis and Treatment - Upon completion of this session, using the ACCP and ATS Guidelines and the Cochrane Abstract Database, the participant should be able to:
| | 1. | Determine the appropriate diagnostic testing for evaluating a patient for VTE based upon the sensitivity and specificity of the diagnostic tests.
| | 2. | Employ the algorithm for diagnosing a PE in multiple clinical settings.
| | 3. | Differentiate the advantages of outpatient treatment compared to inpatient treatment for VTE.
| | 4. | Recommend the appropriate frequency of monitoring and the adjustments needed for warfarin therapy in the treatment of VTE.
| | Pelvic Pain - Upon completion of this session, the participant should be able to:
| | 1. | Assess the patient with acute or chronic pain.
| | 2. | Identify the differential diagnosis and choose appropriate management options for the patient.
| | 3. | Identify true surgical emergencies.
|
| | Day 5 | Adult Health Screening and Immunizations – Evidence-Based Approach - Upon completion of this session, using the USPSTF and Cochrane Abstract Database, the participant should be able to:
| 1. | Apply the evidence-based recommendations for preventive screening tests for adults.
| | 2. | Determine the immunizations required for adults in various clinical encounters.
| | 3. | Determine the side effects of adult immunizations and their management.
| | 4. | Select the contraindications for each adult immunization and their alternative therapy.
| | 5. | Recommend when screening tests can be discontinued in adults.
| | Gynecologic Emergencies - Upon completion of this session, the participant should be able to:
| | 1. | Recognize the more common and significant gynecologic emergencies.
| | 2. | Formulate a rapid and concise treatment plan for various emergencies, such as:
| a. | Ectopic pregnancies,
| | b. | Uterine hemorrhage,
| | c. | Gynecologic infections.
|
| | 3. | Provide follow-up care to the post-gynecologic emergency patient.
| | Use and Interpretation of Thyroid Tests - Upon completion of this session, using the American Thyroid Association Guidelines and the Cochrane Abstract Database, the participant should be able to:
| | 1. | Determine the appropriate serum tests for thyroid function for multiple clinical situations.
| | 2. | Interpret the various combinations of thyroid tests results that occur in clinical settings.
| | 3. | Recommend the appropriate follow-up testing of abnormal thyroid tests and frequency of these evaluations.
| | 4. | Analyze the impact of other medications on thyroid function testing and the evidence-based recommendations for managing the medications’ side effects.
| | Endometriosis - Upon completion of this session, the participant should be able to:
| | 1. | Have a high degree of accuracy in the suspicion of endometriosis based on symptoms and physical examination.
| | 2. | Review current management options with particular attention toward agents that can be effectively used by the primary care provider.
| | 3. | Guide patients with regard to long-term management for pain and/or fertility considerations.
|
|
|